Regulatory news and experts insights.

In December 2025, the European Commission published a targeted legislative proposal under its Food and Feed Safety Simplification Omnibus. One of its most relevant elements for the biocides sector is a proposed amendment to Regulation (EU) No 528/2012 (the Biocidal Products Regulation, or BPR), extending certain data protection periods for active substances still undergoing review.

The Annual Biocontrol Industry Meeting (ABIM) was held in Basel (Switzerland) from 20 to 22 October 2025, bringing together more than 2,000 international participants, including industrial stakeholders, scientific institutes, authorities, professional associations and consulting companies.

The use of any new cosmetic ingredient must be safe. That is a legal obligation according to Article 3 of the European Cosmetic Regulation and in other cosmetic-related laws and standards throughout the world, but also a moral one, as it would be unethical to place on the market a substance that is toxic, or whose toxicity is unknown and for which safe exposure cannot be demonstrated.

Learn how the EU Toy Safety Regulation 2025/2509 strengthens child protection, bans harmful chemicals, and ensures toy compliance across Europe.

Since 13 December 2024, all non-food consumer products in the EU must comply with GPSR (2023/988). Manufacturers and importers must assess risks, maintain technical documentation for 10 years, and notify dangerous products via the Safety Business Gateway. CEHTRA expert Anna Chelle explains how to ensure compliance and protect consumers.

On 13 January 2026, the European Commission’s Joint Research Centre (JRC) published a new report: “JRC technical proposal on EU harmonised waste sorting labels under the packaging and packaging waste regulation”.

COSMETICK is a toxicological and ecotoxicological profile database, combined with a digital cosmetic risk assessment tool. It is designed to support toxicologists and safety assessors in the preparation of Cosmetic Product Safety Reports (CPSR), as well as in the safety assessment of ingredients, impurities, raw materials and fragrance compounds or fragrance concentrates.

In 2025, CEHTRA continued its mission to support industrial companies, institutions and regulated stakeholders in a context marked by increasing regulatory complexity and growing challenges related to the protection of human health and the environment.

Ethylenediamine (EDA, CAS 107-15-3) is a chemical compound widely used as an intermediate in many industrial processes, such as chemical synthesis, resin manufacturing, chelating agents, and additives for lubricating oils. However, due to its hazardous properties, in particular its classification as a respiratory and skin sensitiser, EDA has been identified as a Substance of Very High Concern (SVHC).

In recent years, few regulatory topics have attracted as much attention as endocrine disruptors, chemicals capable of interfering with hormone systems in humans and wildlife. Their potential effects on development, reproduction, and environmental health have prompted increasingly rigorous scrutiny across the globe.

Ensure your cosmetic products are safe and compliant in the EU with a Cosmetic Product Safety Report (CPSR). Learn what it includes, who prepares it, and why it’s legally required under Regulation (EC) No 1223/2009.

La Directive (UE) 2020/2184 établit un cadre harmonisé destiné à garantir la sécurité des matériaux et des produits entrant en contact avec l’eau destinée à la consommation humaine. Pour atteindre cet objectif, elle introduit un dispositif central : les Listes Positives Européennes (EUropean Positive Lists, EUPL).

The REACH Regulation (EC No 1907/2006) aims to ensure a high level of protection for human health and the environment from the risks posed by chemical substances. Among its four main pillars, Registration, Evaluation, Authorisation and Restriction, the Authorisation process is often the most complex for non-specialists to understand. Yet it plays a critical role in managing the most hazardous substances on the European market.

The Directive (EU) 2020/2184, adopted on December 16, 2020, marks a pivotal change in the management of drinking water across EU. It replaces the 1998 directive and aims to ensure universal access to safe and high-quality drinking water while enhancing transparency, monitoring, and risk management. This legislation has significant implications for water suppliers, industries dealing with materials in contact with water, as well as consultants and other stakeholders in the sec

Octocrylene is a widely used ultraviolet (UV) filter in cosmetic products, particularly sunscreens, designed to absorb UVB and part of the UVA spectrum, thereby protecting the skin against the harmful effects of sunlight. Currently, octocrylene is authorised in cosmetic products at a maximum concentration of 9% in accordance with Annex VI of the European Cosmetics Regulation...

L'apparition inattendue d'impuretés de N-nitrosamines dans les médicaments a marqué un tournant réglementaire majeur. Ces composés, connus dans l'environnement et l'alimentation, ont forcé l'industrie pharmaceutique mondiale à revoir ses processus. Face à cette situation, une coordination internationale sans précédent a vu le jour entre les agences réglementaires mondiales, telles que la FDA (États-Unis),

When a company develops a new ingredient, whether it is a concentrated plant extract, a biotech-derived ferment, a processed algae or a “functional” mushroom, one recurring question always arises: is a Novel Food procedure required before marketing the ingredient within the EU? This question often emerges when the project is already well advanced: the formulation is nearly finalized, the marketing identity is ready, the first commercial discussions have started…

The identification of endocrine disruptors (EDs) has become a major public health and environmental concern worldwide. EDs are chemical substances capable of interfering with the hormonal system, leading to adverse effects on both humans and wildlife. Monitoring and assessing these substances is essential to protect human health, particularly among vulnerable populations such as pregnant women, children, and wild species. To this end, the U.S. Environmental Protection Agen

Les substances per- et polyfluoroalkylées (PFAS) font l’objet d’une attention croissante des autorités européennes en raison de leur persistance, bioaccumulation et toxicité.Dans ce contexte, le secteur des produits phytopharmaceutiques (PPP) est désormais scruté de près à travers le rapport de restriction de l’Annexe XV de l’ECHA. Ce rapport indique que les substances actives utilisées dans les PPP, les produits biocides et les produits médicinaux se distinguent chimiquemen

At CEHTRA, regulatory expertise goes beyond compliance. Our strength lies in a human-driven, client-focused approach supported by collective intelligence and responsible scientific commitment.